NCT07880145Not yet recruiting
Effects of Respiratory Muscle Strength Training in Children With Asthma
Evaluation of the Effects of Respiratory Muscle Strength Training in Children With Asthma Within the Framework of the International Classification of Functioning, Disability and Health
Source: ClinicalTrials.gov · Last updated 19 Oct 2026
Brief summary (registry, in English)
Asthma is a common long-term respiratory condition in children. In addition to affecting breathing, asthma may affect physical activity, exercise capacity, daily functioning, and quality of life. Respiratory muscles, particularly the muscles used for breathing in, play an important role in breathing and may also contribute to physical functioning. The purpose of this randomized controlled study is to investigate whether adding inspiratory muscle training to a respiratory exercise program provides additional benefits for children with asthma. The study will evaluate the effects of the training using the International Classification of Functioning, Disability and Health (ICF) framework, which provides a broad approach to understanding health by considering body functions, activities, participation, and related aspects of daily life. Participants will be randomly assigned to one of two groups. Both groups will perform thoracic mobility and thoracic expansion exercises. In addition, one group will receive inspiratory muscle training for 8 weeks. Before and after the 8-week program, participants will undergo assessments of breathing muscle function, lung function, exercise capacity, autonomic function, physical activity, and quality of life. The study aims to determine whether inspiratory muscle training can provide additional improvements in respiratory and physical functioning in children with asthma and to evaluate these effects from a broader perspective using the ICF framework.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 12 Oct 2026
- Start date
- Oct 2026
- Primary completion date
- Jan 2027
- Lead sponsor
- Hasan Kalyoncu University
- Diseases
- Asthma
- NCT number
- NCT07880145
What you commit to
- Study type: Interventional
- Planned participants: 32
- From Oct 2026 to the primary completion date, Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Asthma exacerbation requiring prescription of corticosteroid medication.
- Previous participation in a rehabilitation program.
Other illness
- History of thoracic surgery.
- Presence of other chronic diseases, including neuromuscular, rheumatologic, cardiovascular, or renal diseases.
Who the study is looking for
- Aged between 12 and 18 years.
- Diagnosed with asthma according to the Global Initiative for Asthma (GINA) criteria.
- Clinically stable asthma.
- No increase in asthma medication dosage within the previous 3 months.
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mardin Training and Research Hospital Coordinator of this site? Confirm its status | Mardin | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.